1. Beginning with electrophysiological evidence for two Populations of
receptors for N-methyl-D-aspartate (NMDA) which did or did not respon
d to the agonist quinolinic acid, evidence has grown for such subdivis
ion. 2. Data from binding studies is consistent with differences betwe
en three NMDA receptors in the striatum, thalamus and cerebellum with
respect to their preferences for agonist or antagonist binding and the
modulation of binding by dizocilpine, cations and polyamines. 3. The
recent isolation and sequencing of several different molecular species
of NMDA receptor supports the view that at least two pharmacologicall
y distinct sites exist, with the cerebellar receptor being unique in t
he brain.